Chemical formula: C₁₇H₁₂Cl₂N₄ Molecular mass: 343.21 g/mol PubChem compound: 5556
Triazolam is a short-acting benzodiazepine with anticonvulsant anxiolytic, sedative, muscle relaxant and amnesic properties. It is used as a hypnotic in the short-term management of insomnia.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05CD05 | Triazolam | N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| HALCION Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Triazolam is an active ingredient of these brands:
United States (US)Austria (AT)Estonia (EE)Finland (FI)Germany (DE)Hong Kong (HK)Ireland (IE)Japan (JP)Lithuania (LT)Mexico (MX)New Zealand (NZ)Spain (ES)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
